| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.0071 | 0.9 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-22 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-12 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-10 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.36 | 2e-07 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |